During the past decade, Ki Health Partners, LLC dba New England Institute for Clinical Research conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ki Health Partners, LLC dba New England Institute for Clinical Research" #1 sponsor was "Pfizer" with 8 trials, followed by "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored, "Revance Therapeutics, Inc." with 2 trials sponsored and "Cognition Therapeutics" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ki Health Partners, LLC dba New England Institute for Clinical Research" #1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ki Health Partners, LLC dba New England Institute for Clinical Research" are "Migraine" (7 trials), "Acute Migraine" (1 trials), "Acute Treatment of Migraine" (1 trials), "Alzheimer Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Ki Health Partners, LLC dba New England Institute for Clinical Research" in a lesser frequency.

Most popular intervention types in "Ki Health Partners, LLC dba New England Institute for Clinical Research" are "Drug" (16 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Rimegepant" (4 trials), "Eptinezumab" (2 trials), "Zavegepant" (2 trials) and "BHV-3500 (zavegepant)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ki Health Partners, LLC dba New England Institute for Clinical Research" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Ki Health Partners, LLC dba New England Institute for Clinical Research". undefined are not yet recruiting, 8 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Ki Health Partners, LLC dba New England Institute for Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ki Health Partners, LLC dba New England Institute for Clinical Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".